PIK3CA in ovarian clear cell carcinoma

被引：6
|
作者：
Zannoni, Gian Franco [1 ]
Improta, Giuseppina [2 ]
Fraggetta, Filippo [3 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dept Pathol, I-00168 Rome, Italy
[2] IRCCS CROB Hosp, Lab Clin Res & Adv Diagnost, I-85028 Potenza, Italy
[3] Osped Cannizzaro, Dept Pathol, I-95126 Catania, Italy
来源：
HUMAN PATHOLOGY | 2014年 / 45卷 / 12期
关键词：
MUTATIONS;
D O I：
10.1016/j.humpath.2014.07.023
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：2514 / 2514
页数：1
相关论文
共 50 条
  • [1] Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
    Kuo, Kuan-Ting
    Mao, Tsui-Lien
    Jones, Sian
    Veras, Emanuela
    Ayhan, Ayse
    Wang, Tian-Li
    Glas, Ruth
    Slamon, Dennis
    Velculescu, Victor E.
    Kuman, Robert J.
    Shih, Ie-Ming
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (05): : 1597 - 1601
  • [2] Relationship of PIK3CA mutation between ovarian clear cell carcinoma and endometrium
    Murakami, Kosuke
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Matsumura, Noriomi
    [J]. CANCER SCIENCE, 2021, 112 : 771 - 771
  • [3] Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma
    Rahman, Munmun
    Nakayama, Kentaro
    Rahman, Mohammed Tanjimur
    Nakayama, Naomi
    Ishikawa, Masako
    Katagiri, Atsuko
    Iida, Kouji
    Nakayama, Satoru
    Otsuki, Yoshiro
    Shih, Ie-Ming
    Miyazaki, Kohji
    [J]. HUMAN PATHOLOGY, 2012, 43 (12) : 2197 - 2206
  • [4] Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA
    Hoshino, Hitomi
    Inoue, Daisuke
    Shinagawa, Akiko
    Yoshida, Hisato
    Shigeto, Shohei
    Matsuda, Kazuyuki
    Akama, Tomoya O.
    Yoshida, Yoshio
    Kobayashi, Motohiro
    [J]. HUMAN CELL, 2024, 37 (04) : 1184 - 1193
  • [5] Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
    Murakami, Kosuke
    Kanto, Akiko
    Sakai, Kazuko
    Miyagawa, Chiho
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Kotani, Yasushi
    Nishio, Kazuto
    Matsumura, Noriomi
    [J]. MODERN PATHOLOGY, 2021, 34 (11) : 2071 - 2079
  • [6] PIK3CA Gene Mutations and Amplifications in Chinese Patients With Ovarian Clear Cell Carcinoma
    Jiang, Gaofeng
    Huang, Zhixiong
    Zhang, Shuangling
    Wang, Lin
    [J]. CANCER INVESTIGATION, 2013, 31 (10) : 639 - 644
  • [7] Mutational Status of KRAS, BRAF, NRAS and PIK3CA in Primary Clear Cell Ovarian Carcinoma
    Zannoni, Gian Franco
    Chiarello, Gaia
    Petrillo, Marco
    Improta, Giuseppina
    Rossi, Esther D.
    Fadda, Guido
    Fraggetta, Filippo
    [J]. MODERN PATHOLOGY, 2015, 28 : 316A - 317A
  • [8] PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma
    Abe, Azusa
    Minaguchi, Takeo
    Ochi, Hiroyuki
    Onuki, Mamiko
    Okada, Satoshi
    Matsumoto, Koji
    Satoh, Toyomi
    Oki, Akinori
    Yoshikawa, Hiroyuki
    [J]. HUMAN PATHOLOGY, 2013, 44 (02) : 199 - 207
  • [9] Mutational Status of KRAS, BRAF, NRAS and PIK3CA in Primary Clear Cell Ovarian Carcinoma
    Zannoni, Gian Franco
    Chiarello, Gaia
    Petrillo, Marco
    Improta, Giuseppina
    Rossi, Esther D.
    Fadda, Guido
    Fraggetta, Filippo
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 316A - 317A
  • [10] ZNF217 Gene Amplification and PIK3CA Mutation Are Associated with Ovarian Clear Cell Carcinoma
    Kuo, K. T.
    Mao, T. L.
    Jinawath, N.
    Kurman, R. J.
    Wang, T. L.
    Shih, I. M.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 223A - 223A
12345